Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges

@inproceedings{Pai2015InnovationsIT,
  title={Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges},
  author={Madhukar Pai},
  booktitle={EBioMedicine},
  year={2015}
}
Despite the long and hard battle against tuberculosis (TB), WHO esanalysis of the TB R&D funding landscape by Treatment Action Group timated that 9million people developed the disease in 2013, and nearly 1.5 million people died of TB (World Health Organization, 2014). To make matters worse, drug-resistance is a growing threat, and 3 out of 9 million TB cases are either not diagnosed, or not notified to TB control programs. But there is some good news from the perspective of new tool… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 10 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Molecular drug susceptibility testing — defining assay characteristics for the use at the level of the microscopy center

  • C. M. Denkinger, D. Dolinger, M Schito
  • J. Infect. Dis
  • 2015
2 Excerpts

Similar Papers

Loading similar papers…